Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
The Journal of Clinical Investigation|March 10, 2020
Immunotherapy of multiple myelomaSimone A Minnie, Geoffrey R HillFrontiers in Immunology|March 29, 2021
Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?Simone A Minnie, Geoffrey R HillCurrent Opinion in Immunology|October 11, 2025
Optimizing post-transplantation cell therapies to enhance graft-versus-leukemia effects in hematological malignanciesSimone A Minnie, Melissa M Berrien-Elliott, Melody Smith, et al.Frontiers in Immunology|April 24, 2023
Multiparametric flow cytometry to characterize vaccine-induced polyfunctional T cell responses and T cell/NK cell exhaustion and memory phenotypes in mouse immuno-oncology modelsDavide Moi, Bijun Zeng, Simone A Minnie, et al.Blood|August 30, 2018
Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockadeSimone A Minnie, Rachel D Kuns, Kate H Gartlan, et al.Blood|October 4, 2019
IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signalingAndrew N Wilkinson, Karshing Chang, Rachel D Kuns, et al.Blood|January 31, 2024
Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantationShuichiro Takahashi, Simone A Minnie, Kathleen S Ensbey, et al.Blood|February 20, 2025
Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host diseaseJulie R Boiko, Kathleen S Ensbey, Olivia G Waltner, et al.Blood|July 11, 2018
TIGIT immune checkpoint blockade restores CD8<sup>+</sup> T-cell immunity against multiple myelomaCamille Guillerey, Heidi Harjunpää, Nadège Carrié, et al.Nature Communications|April 14, 2023
Oncogenic drivers dictate immune control of acute myeloid leukemiaRebecca J Austin, Jasmin Straube, Rohit Halder, et al.Pageof 3